These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21849222)

  • 41. The occluding loop of cathepsin B prevents its effective inhibition by human kininogens.
    Naudin C; Lecaille F; Chowdhury S; Krupa JC; Purisima E; Mort JS; Lalmanach G
    J Mol Biol; 2010 Jul; 400(5):1022-35. PubMed ID: 20538006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.
    Sosič I; Mirković B; Arenz K; Stefane B; Kos J; Gobec S
    J Med Chem; 2013 Jan; 56(2):521-33. PubMed ID: 23252745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
    Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
    Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
    Sun L; Bera H; Chui WK
    Eur J Med Chem; 2013 Jul; 65():1-11. PubMed ID: 23688695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
    Hin N; Duvall B; Berry JF; Ferraris DV; Rais R; Alt J; Rojas C; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2088-91. PubMed ID: 26965861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.
    Greenspan PD; Clark KL; Tommasi RA; Cowen SD; McQuire LW; Farley DL; van Duzer JH; Goldberg RL; Zhou H; Du Z; Fitt JJ; Coppa DE; Fang Z; Macchia W; Zhu L; Capparelli MP; Goldstein R; Wigg AM; Doughty JR; Bohacek RS; Knap AK
    J Med Chem; 2001 Dec; 44(26):4524-34. PubMed ID: 11741472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
    Sun L; Li J; Bera H; Dolzhenko AV; Chiu GN; Chui WK
    Eur J Med Chem; 2013; 70():400-10. PubMed ID: 24177367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.
    Mitrović A; Završnik J; Mikhaylov G; Knez D; Pečar Fonović U; Matjan Štefin P; Butinar M; Gobec S; Turk B; Kos J
    Cell Mol Life Sci; 2022 Jan; 79(1):34. PubMed ID: 34989869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cathepsin B and L inhibitors: a patent review (2010 - present).
    Li YY; Fang J; Ao GZ
    Expert Opin Ther Pat; 2017 Jun; 27(6):643-656. PubMed ID: 27998201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regioselective Fluorination of 7-Oxo-1,2,4-benzotriazines Using Selectfluor.
    Mirallai SI; Koutentis PA; Aldabbagh F
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30646524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of anti-cancer activity for benzo[1,2,4]triazin-7-ones: Very strong correlation to pleurotin and thioredoxin reductase inhibition.
    Sweeney M; Coyle R; Kavanagh P; Berezin AA; Lo Re D; Zissimou GA; Koutentis PA; Carty MP; Aldabbagh F
    Bioorg Med Chem; 2016 Aug; 24(16):3565-70. PubMed ID: 27290691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of flavonols and derivatives as human cathepsin B inhibitor.
    Ramalho SD; de Sousa LR; Burger MC; Lima MI; da Silva MF; Fernandes JB; Vieira PC
    Nat Prod Res; 2015; 29(23):2212-4. PubMed ID: 25622620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitors of cathepsin B.
    Frlan R; Gobec S
    Curr Med Chem; 2006; 13(19):2309-27. PubMed ID: 16918357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward very potent, non-covalent organophosphonate inhibitors of cathepsin C and related enzymes by 2-amino-1-hydroxy-alkanephosphonates dipeptides.
    Drąg M; Wieczerzak E; Pawełczak M; Berlicki Ł; Grzonka Z; Kafarski P
    Biochimie; 2013 Aug; 95(8):1640-9. PubMed ID: 23712251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H.
    Raghav N; Garg S
    Eur J Pharm Sci; 2014 Aug; 60():55-63. PubMed ID: 24780403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors.
    Gopalsamy A; Yang H; Ellingboe JW; McKew JC; Tam S; Joseph-McCarthy D; Zhang W; Shen M; Clark JD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2978-81. PubMed ID: 16545564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.
    Mirković B; Sosič I; Gobec S; Kos J
    PLoS One; 2011; 6(11):e27197. PubMed ID: 22073285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and cytotoxicity studies of bifunctional hybrids of nitrogen mustards with potential enzymes inhibitors based on melamine framework.
    Kolesinska B; Barszcz K; Kaminski ZJ; Drozdowska D; Wietrzyk J; Switalska M
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):619-27. PubMed ID: 21899492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 4'-Hydroxy-6,7-methylenedioxy-3-methoxyflavone: A novel flavonoid from Dulacia egleri with potential inhibitory activity against cathepsins B and L.
    de Novais LMR; de Arueira CCO; Ferreira LF; Ribeiro TAN; Sousa PT; Jacinto MJ; de Carvalho MG; Judice WAS; Jesus LOP; de Souza AA; Torquato HFV; Paredes-Gamero EJ; Silva VC
    Fitoterapia; 2019 Jan; 132():26-29. PubMed ID: 30114470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity.
    Mitrović A; Kljun J; Sosič I; Uršič M; Meden A; Gobec S; Kos J; Turel I
    Inorg Chem; 2019 Sep; 58(18):12334-12347. PubMed ID: 31464130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.